Abstract

Several reports have indicated that miR-140, a possible tumor suppressor microRNA (miR), is down-regulated in breast tumors compared with normal breast tissues. However, the role of miR-140 in breast tumorigenesis is unclear. We initiated studies that examined estrogen receptor α (ERα) signaling in the tissue-specific regulation of miR-140 in breast cancer. We found that estrogen stimulation of ERα-positive breast cancer cells resulted in decreased miR-140 expression. We performed promoter analyses and examined predicted ERα binding elements in the miR-140 promoter using luciferase constructs of a miR-140 promoter deletion series. Our studies revealed that ERα binds to one specific estrogen response element flanking the miR-140 promoter and consequently suppresses miR-140 transcription. We found that the stem cell self-renewal regulator SOX2 is a novel target of miR-140, and that this miR-140/SOX2 pathway critically regulates breast tumor-initiating cell survival, providing a new link between ERα signaling and breast cancer stem cell maintenance.

Highlights

  • MiR-140 is down-regulated in non-invasive and invasive breast tumors compared with normal breast tissues

  • Identification of a New Target of miR-140 in Human Breast Cancer Cells, the Stem Cell Self-renewal Regulator SOX2—Previous reports have indicated that miR-140 is down-regulated in breast tumors compared with normal breast tissues [29]

  • Among prospective miR-140 targets, we selected SOX2 mRNA for further investigation since: SOX2 expression is frequently altered in human breast cancers [9], subtle changes in SOX2 dose dictate critical outcomes in cancer stem cell selfrenewal [5, 36], and SOX2 regulation is poorly understood in mammary epithelium

Read more

Summary

Introduction

MiR-140 is down-regulated in non-invasive and invasive breast tumors compared with normal breast tissues. We initiated studies that examined estrogen receptor ␣ (ER␣) signaling in the tissue-specific regulation of miR-140 in breast cancer. We found that estrogen stimulation of ER␣-positive breast cancer cells resulted in decreased miR-140 expression.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.